| Name | HOXA10 antisense RNA |
| Description | Predicted to be involved in miRNA-mediated post-transcriptional gene silencing. Predicted to be part of RISC complex. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n HOXA10‐AS, a long noncoding RNA encoded within the HOXA cluster, has emerged as a versatile regulator of tumor biology in multiple cancer types. In lung adenocarcinoma, HOXA10‐AS is upregulated by the transcription factor ELK1 and promotes tumor progression by enhancing cell proliferation, inhibiting apoptosis, and increasing migratory capacity through activation of Wnt/β‐catenin signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In glioma, elevated expression of HOXA10‐AS correlates with higher tumor grades and poor prognosis; mechanistic studies have shown that it fosters cell growth and survival, in part via upregulation of its sense transcript HOXA10 and modulation of pathways including Hippo signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In oral squamous cell carcinoma, increased HOXA10‐AS levels are positively associated with tumor grade and cell cycle activation, while its silencing decreases proliferation; further, in OSCC stem cells, HOXA10‐AS acts as a competing endogenous RNA by sponging microRNA‑29a, thereby upregulating MCL‑1 and activating the PI3K/AKT pathway to enhance stem cell properties."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In nasopharyngeal carcinoma, HOXA10‐AS facilitates cell proliferation and migration by acting as a sponge for miR‑582‑3p, which leads to the upregulation of RAB31; its expression is transcriptionally activated by E2F1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In acute myeloid leukemia, high levels of HOXA10‐AS—normally expressed in hematopoietic stem cells—contribute to leukemic growth by localizing to the cytoplasm and inducing NF‑κB target genes; knockdown of HOXA10‐AS impairs leukemic proliferation and represents a potential therapeutic target."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In gastric cancer, HOXA10‐AS expression is positively correlated with that of HOXA10, and its overexpression enhances malignant phenotypes including proliferation, migration, and invasion, while its silencing reverses these effects. Mechanistic insights indicate that HOXA10‐AS modulates oncogenic signaling by affecting miRNA‐mediated pathways and is also incorporated into genomic instability–associated prognostic signatures."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "10"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Furthermore, integrative analyses of competing endogenous RNA networks have identified HOXA10‐AS as a robust biomarker of poor outcome in glioblastoma, and additional bioinformatics studies have revealed evolutionarily conserved microRNA binding sites within HOXA10‐AS that likely contribute to its posttranscriptional regulatory functions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings indicate that HOXA10‐AS acts predominantly as an oncogenic lncRNA by modulating cell proliferation, migration, survival, and stem cell properties through diverse mechanisms—including miRNA sponging, upregulation of key oncogenes, and activation of critical signaling cascades—and its consistent association with aggressive tumor phenotypes across cancers underscores its potential as both a prognostic biomarker and a target for therapeutic intervention.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kai Sheng, Jiahuan Lu, Hui Zhao "}, {"type": "b", "children": [{"type": "t", "text": "ELK1-induced upregulation of lncRNA HOXA10-AS promotes lung adenocarcinoma progression by increasing Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.04.224"}], "href": "https://doi.org/10.1016/j.bbrc.2018.04.224"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29729275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29729275"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Cheng-Ya Dong, Jiayue Cui, Dian-He Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2018.6662"}], "href": "https://doi.org/10.3892/or.2018.6662"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30132568"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30132568"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Keren Isaev, Lingyan Jiang, Shuai Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2021.109873"}], "href": "https://doi.org/10.1016/j.celrep.2021.109873"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34686327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34686327"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiaodong Yan, Bin Cong, Qinchao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Int Med Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0300060520934254"}], "href": "https://doi.org/10.1177/0300060520934254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32776855"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32776855"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Dongying Wang "}, {"type": "b", "children": [{"type": "t", "text": "Promotive effects of HOXA10 antisense RNA on the stemness of oral squamous cell carcinoma stem cells through a microRNA-29a/MCL-1/phosphatidyl inositol 3-kinase/protein kinase B axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Oral Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.archoralbio.2021.105114"}], "href": "https://doi.org/10.1016/j.archoralbio.2021.105114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33831733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33831733"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xinyan Wang, Peilan Nie, Dongmei Zhu "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HOXA10-AS Activated by E2F1 Facilitates Proliferation and Migration of Nasopharyngeal Carcinoma Cells Through Sponging miR-582-3p to Upregulate RAB31."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Rhinol Allergy (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/19458924211064400"}], "href": "https://doi.org/10.1177/19458924211064400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35072529"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35072529"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Sina Al-Kershi, Raj Bhayadia, Michelle Ng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Adv (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/bloodadvances.2019032029"}], "href": "https://doi.org/10.1182/bloodadvances.2019032029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31867596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31867596"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Fengyu Cao, Yongbin Zheng, Chao Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "+HOXA10-AS Promotes Malignant Phenotypes of Gastric Cancer via Upregulating HOXA10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Comput Math Methods Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/1846687"}], "href": "https://doi.org/10.1155/2022/1846687"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35222681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35222681"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Shanshan Li, Chuanhui Lu, Xinyu Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HOXA10-AS functions as an oncogene by binding miR-6509-5p to upregulate Y-box binding protein 1 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2059615"}], "href": "https://doi.org/10.1080/21655979.2022.2059615"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35521747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35521747"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zeyu Liu, Yuxiang Wan, Ming Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12935-020-01331-7"}], "href": "https://doi.org/10.1186/s12935-020-01331-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32536823"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32536823"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xin Li, Jingwen Zhang, Min Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000027248"}], "href": "https://doi.org/10.1097/MD.0000000000027248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34596120"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34596120"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "O Yu Yurikova, D E Aisina, R E Niyazova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[The Interaction of miRNA-5p and miRNA-3p with the mRNAs of Orthologous Genes]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol (Mosk) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1134/S0026898419040189"}], "href": "https://doi.org/10.1134/S0026898419040189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31397443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31397443"}]}]}]}
|
| Synonyms | HOXA-AS4 |
| NCBI Gene ID | 100874323 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
HOXA10-AS has 688 functional associations with biological entities spanning 3 categories (chemical, functional term, phrase or reference, cell line, cell type or tissue) extracted from 7 datasets.
Click the + buttons to view associations for HOXA10-AS from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of HOXA10-AS gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of HOXA10-AS gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of HOXA10-AS gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of HOXA10-AS gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of HOXA10-AS gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of HOXA10-AS gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| WikiPathways Pathways 2014 | pathways involving HOXA10-AS protein from the Wikipathways Pathways 2014 dataset. | |